The relationship between Rheumatoid Arthritis (RA) and Autoimmune Thyroid disturbance is one of the numerous examples of autoimmune comorbidities that are already established. This has been investigated in many countries and different populations, but data are still missing in some countries. We aimed to investigate comorbid RA and autoimmune thyroid disturbance in the Saudi population.
INTRODUCTION
The link between rheumatoid arthritis (RA) and autoimmune thyroid disease (AITD) has been an area of interest as early as the 1960's [1] . This presumed association has been researched in various parts of the world, with mixed results; some studies found an association does indeed exist, while other papers disputed this relationship [2] , including some parts of the Middle East, such as Egypt and Kuwait [1, [3] [4] [5] [6] . In Saudi Arabia, there is little epidemiological data about rheumatoid arthritis, in general, and the only study performed in 1998, by Al-Dalaan et al, describes the prevalence of RA in the region of Al-Qassim, estimating it to 2.2 per thousand people [7] . However, due the limited area where this study was conducted, as well as the diverse environments and ethnic backgrounds of people in the different regions of this large country, this data cannot be representative of the whole population of Saudi Arabia. Similarly, data regarding the prevalence of autoimmune thyroid disease is also scarce in Saudi Arabia. A study by Akbar et al. (2006) estimated thyroid dysfunction at 7% in healthy, non-diabetics as compared to patients with type 2 diabetes [8] .
Given the autoimmune nature of both diseases and the reported data from the other areas of the Middle East, some Saudi physicians may expect the coexistence of AITD with RA and do appropriately screen their patients. However, availability of national data on the prevalence of that comorbidity would be very useful for the Saudi physicians, as well as for authorities, to determine a standard level of clinical awareness or to further investigate reliability and cost-effectiveness of systematic screening.
The objective of our study was to determine the prevalence of the coexistence of thyroid dysfunction with rheumatoid arthritis in Saudi Arabia, in a cohort of 151 RA patients presenting to the Rheumatology Clinic at a teaching hospital in Jeddah, in western region of Saudi Arabia.
MATERIALS AND METHODS
This retrospective study was conducted in 2013, at King Abdulaziz University Hospital (KAUH), a teaching hospital in Jeddah. The study was approved by the Biomedical Ethical Research Committee of the Faculty of Medicine of King Abdulaziz University (KAU).
We reviewed the files of all RA patients diagnosed and/or followed up) in the hospital, from 2000 to 2013. RA patients were diagnosed using the 9 th edition of the International Classification of Diseases (ICD-9), codes for RA (714.0-714.33); but we reevaluated the files to include only patients who fulfill the 2010 ACR/European League Against Rheumatism (EULAR) classification criteria for rheumatoid arthritis [9] . The other inclusion criterion was the availability in the patient's record of thyroid function test results.
The following data were collected from the patients' files: demographic features, duration of the disease at the time of the study (in years -yrs), history of thyroid disease, and use of thyroid replacement. 
Statistical Analysis
Data analysis was done using Statistical Package for Social Sciences (SPSS software version-20). Means and standard deviations were calculated for quantitative data and proportions for categorical variables. To establish the relationship between categorical variables, Chi square testing was used and Independent t-test was used between continues variables with normal distribution assumed. Furthermore, regardless of categories, Pearson correlation Test was used to check the dependency of two continues variables. A P-value <0.05 is considered in rejecting null hypothesis.
RESULTS
One hundred and fifty one (151) RA patients were available with TFT done. 119 patients (88%) were women. The mean (±SD) age at the time of the study was 46.96 (±12.5) years for females and 44.6 (±13.2) for males. Sixty-three (41.7%) of our patients were Saudi. The mean (SD) duration of the disease, at the time of the study, was 6.14 years (+ 6). Only 24 patients (16%) were receiving thyroid treatment. The mean ESR was 27.48 mm/hr (+27.48), and mean CRP 12.9(+12.9) mg/L. RF was positive in 84 patients (56%), while the anti-CCP was positive in 77 patients (51%).
The following TFT abnormalities were detected: Subclinical hypothyroidism: in 29 patients (19.2%), Hypothyroidism: in 6 patients (4%), Subclinical hyperthyroidism: in 4 patients (2.6%) and the least was Hyperthyroidism: in 1 patient (0.7%). No patients were recorded as Euthyroid sick syndrome. Table 1 shows the frequency of thyroid disturbance in RA patients. By Chi-square testing there was a significant association between clinical hypothyroidism and RF (P=0.027). Table 2 demonstrates the association between the thyroid status and RF, anti-CCP and CRP.
By Pearson correlation, there was a significant positive correlation between TSH and CRP (r=0.22, P=0.029), which means the higher the CRP, the higher TSH and the more the patient is likely to have either clinical hypothyroidism or subclinical hypothyroidism.
DISCUSSION
We conducted this retrospective cross-sectional study to assess the co-existence of thyroid dysfunction in a cohort of RA patients presenting to the Rheumatology Outpatient Department at a University Teaching Hospital. All patients had proven RA as described in the Methods section, and data was collected from their files regarding thyroid status.
Data regarding thyroid disease in Saudi Arabia is scarce, with very little information detailing the patterns of thyroid dysfunction in the Kingdom. One study by Akbar et al. in 2006 [8] found that thyroid autoimmunity existed in 5% of non-diabetic individuals, while thyroid dysfunction from any etiology was diagnosed in 7% of non-diabetics.
Autoimmune disease tends to affect females more than males, with varying frequency according to disease and organ/body system. Ngo et al. found that rheumatoid arthritis was more frequent in females than males, with a 66-86% higher rate in females. Autoimmune thyroid disease in all its forms was also found to be more frequent in females than males in this paper [10] .
There is a high frequency of comorbid thyroid dysfunction in RA, since 27% of patients in our cohort have significant abnormal thyroid results in their laboratory records. The most frequent thyroid dysfunction found was subclinical hypothyroidism with 19.2% of the patients.
The definition of hypothyroidism based on TSH values is under continued debate. In our study, we have considered 4.1 IU/mL as an upper limit [11, 12] , a TSH range of 4.1-10 IU/mL plus symptoms to diagnose subclinical hypothyroidism and a TSH above 10 IU/mL to diagnose clinical hypothyroidism.
Thyroid dysfunction of autoimmune etiology has long been linked to other autoimmune diseases. El-Sherif et al. published data demonstrating that in a cohort of Egyptian patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), thyroid dysfunction was found in 50% of SLE patients and 15% of RA patients [4] .
Several genes were established to carry an increased risk of developing autoimmune thyroid disease, including CD40, CTLA4, PTPN22, TSH receptor gene, thyroglobulin gene and HLA gene complex [2, [13] [14] [15] . Some of these genes, such as CD40, CTLA4, PTPN22, and also, the HLA gene complex play a role in the development of rheumatoid arthritis [14] . This overlap may explain the co-existence of these conditions. While many causes for hypothyroidism exist, the most common cause, especially in older women, remains autoimmune thyroiditis (Hashimoto's thyroiditis) [16] . This population of patients is also presumed to be at risk for developing other autoimmune diseases such as RA.
The common autoimmune etiology for both RA and AITD makes their co-existence sound logical and even somehow expected, but the exact mechanism by which they coexist remains unclear. Many theories have been proposed to explain this co-existence, one of which suggested that auto-reactive cells responsible for the underlying pathology in RA may also provoke an autoimmune thyroiditis causing Hashimoto's thyroiditis [3] . Also, environmental factors may precipitate these events [17, 18] .
In our study, further analysis of presence of RA markers and markers of inflammation revealed a statistically significant association between RF-positive RA and clinical hypothyroidism, where 4.9% of patients with both diseases having positive RF (P=0.027). Anti-CCP was not found to have a significant presence in co-existing RA and thyroid dysfunction, while CRP was elevated (3.21%) without a statistical significance (P=0.073). Whether these markers represent a significant relationship between the presence of clinical hypothyroidism and RA disease activity should be assessed further. The response of the levels of inflammatory markers to treatment of the thyroid disease should also be examined.
Given our findings, it appears that RA and autoimmune thyroid dysfunction are indeed linked. However, it is difficult to assess retrospectively which disorder predates the other, or if in fact there is such a temporal relationship.
It is be prudent to recommend screening patients with RA for thyroid dysfunction, perhaps more rigorously and frequently than in normal population. Symptoms of thyroid dysfunction should screened for routinely in patients with RA, and more frequent testing for thyroid disease should be undertaken if symptoms suggestive of dysfunction are detected. On the other hand, these symptoms should be systematically and scrupulously researched in the RA patients, all over their follow-up, given this high prevalence of comorbid thyroid dysfunction demonstrated by our study. For example, fatigue is a frequent symptom in patients with RA, and is also a symptom of hypothyroidism; therefore, screening for hypothyroidism -due to a further co-existing AITD-should be considered, especially if other causes of fatigue have been ruled out and pain controlled [19] . However, our study did not assess the effect of treating thyroid dysfunction on rheumatoid arthritis disease activity. Looking forward, examining the effect of treating thyroid dysfunction in patients with established RA on RA disease activity, symptomatology, and prognosis, as well as patient quality of life, is our next area of research. Screening for onset of thyroid dysfunction in established RA is another area of interest, as is establishing an idea of lag time between the onset of RA and AITD.
CONCLUSION
There is a high frequency of comorbid hypothyroidism in our RA patients, in Saudi Arabia, which suggests a high prevalence of Hashimoto's thyroiditis or other auto-immune thyroid dysfunctions, in these patients. Physicians should be aware of screening periodically RA patients for this comorbidity, especially when the specific symptoms may overlap between both diseases. Furthermore, the effect of treating thyroid dysfunctions in patients with established RA on RA disease activity could be an interesting area of research.
